US Stocks Likely To Open On A Mixed Note: Intel, Philips 66, Centene, Charter Earnings In Focus U.S. stock futures swung between gains and losses on Friday after ending on a mixed note on Thursday. Futures were mixed.
NXTC Stock Earnings: NextCure Beats EPS for Q4 2023 NXTC stock results show that NextCure beat analyst estimates for earnings per share the fourth quarter of 2023.
Thursday's after hours session: top gainers and losers After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Monday's session: top gainers and losers Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.
NextCure Inks $745M Deal With Simcere For Cancer Drug: Retail’s More Optimistic Despite Stock’s 27% Decline The newly announced partnership aims to develop SIM0505, a novel antibody-drug conjugate developed by Simcere Zaiming for the treatment of solid tumors.
Stay updated with the stocks that are on the move in today's pre-market session. Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
NXTC Stock Earnings: NextCure Misses EPS for Q2 2024 NXTC stock results show that NextCure missed analyst estimates for earnings per share the second quarter of 2024.
NXTC Stock Earnings: NextCure Misses EPS for Q1 2024 NXTC stock results show that NextCure missed analyst estimates for earnings per share the first quarter of 2024.
Wall Street’s Favorite Penny Stocks? 7 Names That Could Make You Filthy Rich The market is surging higher after dovish Fed comments. Here are seven of Wall Street’s favorite penny stocks that can help make you rich
